Ignite Creation Date:
2024-05-06 @ 2:20 AM
Last Modification Date:
2024-10-26 @ 11:16 AM
Study NCT ID:
NCT02013219
Status:
COMPLETED
Last Update Posted:
2020-04-21
First Post:
2013-12-11
Brief Title:
A Phase 1b Study of Atezolizumab in Combination With Erlotinib or Alectinib in Participants With Non-Small Cell Lung Cancer NSCLC
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Organization Data
Organization:
Hoffmann-La Roche
Class:
INDUSTRY
Study ID:
WP29158
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Hoffmann-La Roche
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None